PatternsRadar
Sign in

ZYDUSLIFEZydus Lifesciences Limited

NSEF&O
1,200.00INR-2.90 (-0.24%)Close · 20 Nov 2026
4 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1.20L CrMarket cap
28.6P/E (TTM)
62.8%Delivery

Filings & corporate actions

87 results filed
CSV
Next results · Q3 FY27
Expected 3 Feb 2027 – 9 Feb 2027
Estimate: filed 34–40 days after quarter end, last 5 times
Dividend
₹1.00 per share · last 24 Jul 2026
2026
  • 4 NovresultsResults · Q2 FY27 · consolidated and standalone+0.4%NSE
  • 7 OctshareholdingShareholding · 30 Sept 2026-0.6%NSE
  • 11 AugresultsResults · Q1 FY27 · consolidated and standalone+1.2%NSE
  • 24 JuldividendDividend · ₹1.00 per share-0.5%
  • 11 JulshareholdingShareholding · 30 Jun 2026-1.7%NSE
  • 24 JunshareholdingShareholding · 18 Jun 2026-1.2%NSE
  • 29 MaybuybackBuy Back-0.7%
  • 19 MayresultsResults · Q4 FY26 · consolidated and standalone+2.2%NSE
  • 9 AprshareholdingShareholding · 31 Mar 2026+1.2%NSE
  • 9 FebresultsResults · Q3 FY26 · consolidated and standalone-3.9%NSE
  • 7 JanshareholdingShareholding · 31 Dec 2025-0.4%NSE

Reaction to results · all yearsrose on day 0 in 42 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY274 Nov 2026+0.4%+1.5%—1.5×
Q1 FY2711 Aug 2026+1.2%-7.3%-5.3%3.4×
Q4 FY2619 May 2026+2.2%+6.6%+5.4%10.1×
Q3 FY269 Feb 2026-3.9%-1.8%-0.2%3.5×
Q2 FY266 Nov 2025+0.8%+0.8%-0.6%0.8×
Q1 FY2612 Aug 2025+3.4%+3.2%+9.3%2.3×
Q4 FY2520 May 2025+0.7%+4.8%+8.5%1.6×
Q3 FY255 Feb 2025+3.2%-3.5%-7.8%5.9×
Q2 FY2512 Nov 2024+1.5%-0.1%+3.0%1.7×
Q1 FY259 Aug 2024-3.9%-8.3%-14.4%1.6×
Q4 FY2417 May 2024+5.0%+0.7%+2.6%0.0×
Q3 FY249 Feb 2024+6.4%+12.7%+23.5%5.6×
Q2 FY247 Nov 2023+4.7%+4.0%+10.2%4.5×
Q1 FY2411 Aug 2023-1.0%-0.7%-4.5%3.0×
Q4 FY2318 May 2023-2.6%0.0%+8.5%3.5×
Q3 FY233 Feb 2023+0.4%+9.4%+9.3%1.2×
Q2 FY2311 Nov 2022-1.3%-7.5%-5.5%0.9×
Q1 FY2310 Aug 2022+1.1%+9.2%+3.7%1.2×
Q4 FY2220 May 2022+1.6%+5.8%-6.3%2.6×
Q3 FY223 Feb 2022-1.6%-3.2%-16.5%1.3×
Q2 FY2229 Oct 2021+2.3%+0.6%-5.4%2.1×
Q1 FY2211 Aug 2021-2.2%-5.8%-3.2%2.2×
Q4 FY2127 May 2021-0.2%+1.0%-1.6%1.2×
Q3 FY215 Feb 2021-0.4%-1.7%-6.1%1.0×
Q2 FY212 Nov 2020+6.6%-0.3%+12.7%6.5×
Q1 FY215 Aug 2020-1.9%-4.6%-5.4%4.1×
Q4 FY2019 Jun 2020-1.0%-0.5%+3.2%1.0×
Q3 FY205 Feb 2020+0.5%-1.0%-2.0%4.8×
Q2 FY2013 Nov 2019+4.2%+13.2%+17.5%3.8×
Q1 FY209 Aug 2019-4.6%-7.0%+5.0%1.5×
Q4 FY1929 May 2019-2.6%-8.0%-8.4%0.9×
Q3 FY1919 Feb 2019+0.4%+2.5%+6.7%0.5×
Q2 FY1921 Nov 2018-1.3%+1.9%-4.7%0.5×
Q1 FY1923 Aug 2018+1.8%+2.9%+0.7%1.2×
Q4 FY1825 Jun 2018-2.3%-6.2%-9.7%0.4×
Q3 FY1812 Mar 2018+0.3%-1.0%+0.2%0.9×
Q2 FY1821 Nov 2017+0.7%-1.0%-6.3%0.8×
Q1 FY1824 Aug 2017+1.5%+2.4%-2.5%1.3×
Q4 FY1730 May 2017+3.5%+7.4%+15.8%1.5×
Q3 FY176 Feb 2017+0.8%+2.2%+19.5%0.9×
Q2 FY177 Nov 2016-1.6%-8.1%+1.1%0.9×
Q1 FY1726 Sept 2016-0.2%-1.1%-1.7%0.6×
Q4 FY1623 May 2016+0.9%+3.9%-1.9%0.7×
Q3 FY165 Feb 2016+0.2%-3.6%+2.8%0.7×
Q2 FY1623 Oct 2015+2.7%-3.4%-1.7%3.2×
Q1 FY1612 Aug 2015-3.3%-3.8%-11.3%1.3×
Q4 FY1521 May 2015-0.2%+6.3%+1.6%1.9×
Q3 FY1519 Feb 2015-1.7%-6.0%-1.3%0.2×
Q2 FY1513 Nov 2014-0.3%-1.7%+3.2%1.7×
Q1 FY157 Aug 2014+0.4%+1.8%+18.0%0.4×
Q4 FY1417 Jun 2014+0.6%+2.9%+11.3%0.7×
Q3 FY147 Feb 2014+5.7%+10.8%+16.4%12.0×
Q2 FY146 Nov 2013+2.7%+4.6%+4.8%3.1×
Q1 FY1417 Aug 2013-2.7%-1.6%+0.4%2.5×
Q4 FY1310 Jun 2013-1.0%+1.7%+3.7%1.6×
Q3 FY138 Feb 2013-2.8%-7.6%-8.5%5.5×
Q2 FY137 Nov 2012-3.1%-6.7%-4.4%7.1×
Q1 FY137 Aug 2012-1.9%-3.8%-1.9%0.8×
Q4 FY1210 May 2012+0.9%+3.9%-3.3%2.0×
Q3 FY127 Feb 2012-2.1%+7.5%+3.4%2.7×
Q2 FY1210 Nov 2011-5.0%-5.9%-8.0%1.5×
Q1 FY1219 Jul 2011-0.6%-6.7%-12.7%1.8×
Q4 FY116 May 2011+2.7%+5.9%+5.9%3.1×
Q3 FY1118 Jan 2011-1.3%+8.6%+1.6%3.6×
Q2 FY1119 Oct 2010-1.2%+4.0%+15.2%0.9×
Q1 FY1127 Jul 2010+0.7%-1.6%-2.6%2.6×
Q4 FY1029 Apr 2010-0.3%+2.4%+6.9%1.9×
Q3 FY1025 Jan 2010+7.1%+7.7%+14.0%11.6×
Q2 FY1027 Oct 2009+1.2%+0.6%+9.2%1.6×
Q1 FY1027 Jul 2009+3.1%+19.0%+15.9%1.8×
Q4 FY0928 Apr 2009-1.3%+7.9%+6.4%1.1×
Q3 FY0927 Jan 2009+2.0%+8.7%+9.1%0.8×
Q2 FY0922 Oct 2008-1.1%-10.3%-12.5%0.1×
Q1 FY0929 Jul 2008+2.3%+11.6%+6.1%1.2×
Q4 FY0829 Apr 2008+6.1%+13.0%+9.2%3.7×
Q3 FY0831 Jan 2008-3.8%-3.1%-1.6%0.3×
Q2 FY0826 Oct 2007-1.1%+2.0%-5.2%1.8×
Q1 FY0831 Jul 2007-0.7%+2.2%-14.3%1.3×
Q4 FY0726 Apr 2007+0.7%+0.8%+2.5%1.5×
Average+0.3%+1.1%+1.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+29.2%
Profit YoY-26.5%
Interest cost YoY+102.3%
Revenue QoQ-1.3%
Profit QoQ-1.5%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+18.9%+17.2%+17.9%+14.5%+12.7%+11.5%
Profit+14.6%+14.2%+21.2%-2.7%+16.3%+17.1%

Key data

Open1,200.00
Day range1,193.50 – 1,208.50
52-week range835.50 – 1,266.60
From 52w high-5.3%
RSI (14)54.4
ATR (14)28.49
Volume7.80L
Avg volume (20D)15.90L
Rel volume0.49×
Volatility (1Y)24.3%
Turnover₹93.7Cr
Traded value (NSE)₹93.7Cr
VWAP1,200.65
SMA 50 / 2001,166.18 / 1,056.53
Price bandNo band
MWPL used26.5%

Delivery percentage

Latest · 20 Nov 202662.8%
20-day avg50.2%
1-year avg50.2%
Percentile (own history)79th
Range7.5–100.0%
Sessions3,629

Over the last 20 sessions ZYDUSLIFE settled 50.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 50.2%. The latest session ranks higher than 79% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.08%
Dividend, trailing 12M₹1.00
Paid every year for6 yr
Shareholders3.82L · -4.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy2,733 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.24%+0.85%+5.73%+8.33%+15.78%+27.06%

Valuation

Market cap₹1.20L Cr
Market cap (NSE)₹1.20L Cr
Free-float cap₹29,913 Cr
P/E (TTM)28.6
P/E (NSE)28.0
EPS (TTM)41.90
P/B4.3
Net margin (TTM)13.8%
Other income / PBT8.7%
ROE15.7%
Debt / equity0.44
Shares outstanding99.80Cr
Listed18 Apr 2000

Ownership

Promoter75.01%
Promoter Δ QoQ0.00 pp
Public24.99%
FII7.05%
DII11.28%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)6,864.57,587.08,017.07,909.6
YoY chg+30.3%+16.2%+22.0%+29.2%
Net profit (₹ Cr)1,022.91,341.0990.2927.7
YoY chg-0.3%+7.8%-34.9%-25.1%
Net margin14.9%17.7%12.4%11.7%
EPS10.3612.659.359.28

Shareholding over time

By quarter

30 Sept 2026 · promoter 75.01% · public 24.99%
30 Sept 2021: promoter 74.88%31 Dec 2021: promoter 74.88%31 Mar 2022: promoter 74.88%30 Jun 2022: promoter 74.88%30 Sept 2022: promoter 74.98%31 Dec 2022: promoter 74.98%31 Mar 2023: promoter 74.98%30 Jun 2023: promoter 74.98%30 Sept 2023: promoter 74.98%31 Dec 2023: promoter 74.98%31 Mar 2024: promoter 74.98%30 Jun 2024: promoter 74.98%30 Sept 2024: promoter 74.98%31 Dec 2024: promoter 74.98%31 Mar 2025: promoter 74.99%30 Jun 2025: promoter 74.99%30 Sept 2025: promoter 74.99%31 Dec 2025: promoter 75.00%31 Mar 2026: promoter 75.00%18 Jun 2026: promoter 75.01%30 Jun 2026: promoter 75.01%30 Sept 2026: promoter 75.01%
2021-092026-09
  • Promoter
  • Public and others
Promoter
75.01%
Public
24.99%
Promoter change
0.00 pp
Filed
7 Oct 2026
FII
7.05%
DII
11.28%
Promoter pledged
0.00%

Who the public is

Mutual funds
6.88%

+1.76 pp QoQ

Insurance
4.20%

-1.76 pp QoQ

FPI
7.05%

+0.16 pp QoQ

Retail ≤ ₹2L
4.56%

-0.15 pp QoQ

HNI > ₹2L
0.74%

0.00 pp QoQ

NRI
0.35%

+0.01 pp QoQ

Bodies corporate
0.58%

-0.02 pp QoQ

Shareholders
3,82,067

-4.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Zydus Family Trust (Pankaj R. Patel, Pritiben P. Patel and Sharvil P. Patel-Trustees)Promoter · Other74.98%
Life Insurance Corporation Of IndiaInsurance3.77%
Parag Parikh Flexi Cap FundMutual fund2.01%
Quant Mutual Fund - Quant Multi Cap FundMutual fund1.49%
Kotak Flexicap FundMutual fund1.07%
Arati Rajiv MehtaPromoter · Individual0.01%
Pankaj Ramanbhai PatelPromoter · Individual0.00%
Pankaj Ramanbhai Patel HUF (Pankaj Ramanbhai Patel-Karta)Promoter · Individual0.00%
Pritiben Pankajbhai PatelPromoter · Individual0.00%
Sharvil Pankajbhai PatelPromoter · Individual0.00%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 26 Jul 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹1.00₹1.00
FY2025-261₹11.00₹11.00
FY2024-251₹3.00₹3.00
FY2023-241₹6.00₹6.00
FY2022-231₹2.50₹2.50
FY2021-221₹3.50₹3.50
FY2019-202₹7.00₹7.00
FY2018-191₹3.50₹3.50
FY2016-171₹3.20₹3.20
FY2015-162₹15.20₹5.60
FY2014-151₹9.00₹1.80
FY2013-141₹7.50₹1.50
FY2012-131₹7.50₹1.50
Ex-dateRecord dateDeclaredAdjusted
24 Jul 2026—₹1.00₹1.00
25 Jul 2025—₹11.00₹11.00
26 Jul 2024—₹3.00₹3.00
28 Jul 2023—₹6.00₹6.00
28 Jul 2022—₹2.50₹2.50
28 Jul 2021—₹3.50₹3.50
23 Mar 2020—₹3.50₹3.50
25 Jul 2019—₹3.50₹3.50
31 Jul 2018—₹3.50₹3.50
16 Mar 2017—₹3.20₹3.20
17 Mar 2016—₹3.20₹3.20
30 Jul 2015—₹12.00₹2.40
17 Jul 2014—₹9.00₹1.80
11 Jun 2013—₹7.50₹1.50
26 Jul 2012—₹7.50₹1.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
12 months ago
Disclosures on record
91
32 open-market of the newest 91
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
17 Nov 2025Jasodaben Babubhai PatelPromoterBuy1.0K₹9.6L963.5241.6K → 42.6K0.00%0.00 pp7(2)told 14 Nov 2025
29 Mar 2024DEVAL DHIRAJBHAI SHAHRelativeSell292₹2.9L1,006.64292 → —0.00%7(2)told 29 Mar 2024
29 Mar 2024ZYDUS FAMILY TRUSTPromoterSell30.0K₹3.0Cr1,010.6275.43Cr → 75.43Cr74.96%-0.00 pp7(2)told 29 Mar 2024
29 Mar 2024ZYDUS FAMILY TRUSTPromoterSell10.0K₹1.0Cr1,006.6875.44Cr → 75.43Cr74.97%-0.00 pp7(2)told 29 Mar 2024
28 Mar 2024DEVAL DHIRAJBHAI SHAHRelativeSell150₹1.5L1,010.92442 → 2920.00%0.00 pp7(2)told 27 Mar 2024
28 Mar 2024DEVAL DHIRAJBHAI SHAHRelativeSell500₹4.9L985.57942 → 4420.00%0.00 pp7(2)told 27 Mar 2024
28 Mar 2024ZYDUS FAMILY TRUSTPromoterSell5.65L₹57.0Cr1,008.6675.49Cr → 75.44Cr74.97%-0.06 pp7(2)told 28 Mar 2024
28 Mar 2024ZYDUS FAMILY TRUSTPromoterSell17.5K₹1.8Cr1,015.3575.49Cr → 75.49Cr75.02%-0.00 pp7(2)told 28 Mar 2024
27 Mar 2024HARSHA JYOTINDRA GORRelativeSell1.0K₹10.1L1,009.073.5K → 2.5K0.00%0.00 pp7(2)told 27 Mar 2024
22 Mar 2024Vishal J. GorOtherSell862₹8.3L965.98862 → —0.00%7(2)told 21 Mar 2024
31 May 2022Nitinbhai Raojibhai Desai HUFOtherBuy14.5K₹54.6L376.2275.5K → 90.0K0.01%+0.00 pp7(2)told 30 May 2022
31 May 2022Sheetal Rajan NavaniRelativeBuy15.0K₹56.4L375.981.44L → 1.59L0.01%+0.00 pp7(2)told 30 May 2022
31 May 2022Desons Holdings and Finance Pvt. LimitedOtherBuy15.0K₹56.4L376.0119.98L → 20.13L0.20%+0.00 pp7(2)told 30 May 2022
30 May 2022Nitinbhai Raojibhai Desai HUFOtherBuy500₹1.9L373.1075.0K → 75.5K0.01%+0.00 pp7(2)told 30 May 2022
27 May 2022Nitin Raojibhai DesaiDirectorBuy15.0K₹55.7L371.363.67L → 3.82L0.04%+0.00 pp7(2)told 27 May 2022
23 Sept 2021NITINKUMAR DALSUKHRAY PAREKHKMPSell10.0K₹55.3L553.4710.0K → —0.00%7(2)told 23 Sept 2021
22 Sept 2021NITINKUMAR DALSUKHRAY PAREKHKMPSell20.0K₹1.1Cr540.5930.0K → 10.0K0.00%0.00 pp7(2)told 22 Sept 2021
2 Jun 2021RUPA N. PAREKHRelativeSell10.0K₹61.8L617.8810.0K → —0.00%7(2)told 2 Jun 2021
2 Jun 2021NITIN D. PAREKHKMPSell10.0K₹61.8L617.7240.0K → 30.0K0.00%0.00 pp7(2)told 2 Jun 2021
20 Mar 2020Rupa Nitinkumar ParekhRelativeSell10.0K₹28.9L288.5720.0K → 10.0K0.00%0.00 pp7(2)told 20 Mar 2020
6 Sept 2019Zydus Family TrustPromoterBuy2.51L₹5.7Cr226.4376.61Cr → 76.64Cr74.86%+0.02 pp7(2)told 4 Sept 2019
6 Sept 2019Zydus Family TrustPromoterBuy17.5K₹39.8L227.5176.61Cr → 76.61Cr74.83%+0.00 pp7(2)told 4 Sept 2019
4 Sept 2019Zydus Family TrustPromoterBuy2.34L₹5.3Cr226.9876.59Cr → 76.61Cr74.83%+0.02 pp7(2)told 3 Sept 2019
4 Sept 2019Zydus Family TrustPromoterBuy17.4K₹39.1L224.5276.59Cr → 76.59Cr74.81%+0.00 pp7(2)told 3 Sept 2019
31 Aug 2019Zydus Family TrustPromoterBuy1.08L₹2.4Cr225.4176.58Cr → 76.59Cr74.81%+0.01 pp7(2)told 30 Aug 2019
31 Aug 2019Zydus Family TrustPromoterBuy7.4K₹16.7L225.2076.57Cr → 76.58Cr74.80%+0.00 pp7(2)told 30 Aug 2019
30 Aug 2019Zydus Family TrustPromoterBuy2.09L₹4.6Cr220.9576.55Cr → 76.57Cr74.80%+0.02 pp7(2)told 29 Aug 2019
15 Jun 2019Harish SadanaEmployeeBuy2.5K₹6.2L247.88— → 2.5K0.00%7(2)told 14 Jun 2019
29 May 2018GANESH NARAYAN NAYAKDirectorBuy1.00L₹3.9Cr390.041.51L → 2.51L0.02%+0.01 pp7(2)told 29 May 2018
28 Mar 2018RAMANBHAI B PATEL HUFPromoterSell15.0K₹58.0L386.6415.0K → —0.00%7(2)told 27 Mar 2018
28 Mar 2018PANKAJ RAMANBHAI PATEL HUFPromoterBuy15.0K₹58.2L388.1315.0K → 30.0K0.00%0.00 pp7(2)told 27 Mar 2018
23 Aug 2017NITIN D. PAREKHRelativeBuy20.0K₹96.4L481.9340.0K → 60.0K0.01%+0.00 pp7(2)told 22 Aug 2017

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 30 Aug 2024

CSV
12 of 13 deals
By year
DateDealClientQuantityPriceValue
30 Aug 2024Sell · bulkUBS PRINCIPAL CAPITAL ASIA LIMITED67.02L1,128.11₹756.0Cr
28 May 2019Buy · bulkINTEGRATED CORE STRATEGIES (ASIA) PTE.LTD. · as CADILAHC54.60L258.21₹141.0Cr
30 Nov 2015Buy · bulkBLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF · as CADILAHC71.03L403.00₹286.2Cr
30 Nov 2015Sell · bulkBLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF · as CADILAHC5.55L402.79₹22.4Cr
27 Oct 2015Buy · blockBARCLAYS MERCHANT BANK (SINGAPORE) LTD · as CADILAHC46.04L427.75₹197.0Cr
27 Oct 2015Sell · blockBARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD · as CADILAHC46.04L427.75₹197.0Cr
20 Oct 2015Buy · blockBARCLAYS MERCHANT BANK (SINGAPORE) LTD · as CADILAHC21.70L435.50₹94.5Cr
20 Oct 2015Sell · blockBARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD · as CADILAHC21.70L435.50₹94.5Cr
14 Oct 2015Buy · blockBARCLAYS MERCHANT BANK (SINGAPORE) LTD · as CADILAHC15.60L424.00₹66.1Cr
14 Oct 2015Sell · blockBARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD · as CADILAHC15.60L424.00₹66.1Cr
10 Dec 2007Buy · bulkDALI LIMITED · as CADILAHC18.81L292.00₹54.9Cr
10 Dec 2007Sell · bulkHSBC GLOBAL INVESTMENT FU NDS MAURITIUS LTD · as CADILAHC16.30L292.00₹47.6Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to ZYDUSLIFE.

Price band: No band · not in the F&O ban · 26.5% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes · ban days · MWPL.

Every stock on this session →

Futures & options · 20 Nov 2026

CSV

Long unwinding — price down as positions closed — longs exiting.

Futures OI
1.00Cr

₹1,205.4Cr

OI change
-4.12%
Basis
-0.24%
Rollover
84.7%
PCR (OI)
0.61
PCR (volume)
0.71
Front settle
1,197.00
Lot size
450

shares

Futures volume
16.9K

contracts

Futures trades
11,716
Futures value
₹916.8Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Option chain · 20 Nov 2026 · lot 450

Put OICall OI
Max pain
1,220

+1.7% from spot

Call OI wall
1,250
Put OI wall
1,100
PCR (OI, this expiry)
0.68
PutsStrikeCalls
1,080
1,090
1,100PW
1,110
1,120
1,130
1,140
1,150
1,160
1,170
1,180
1,190
Spot 1,199.88
1,200
1,210
1,220MP
1,230
1,240
1,250CW
1,260
1,270
1,280
1,290
1,300
1,310
1,320

1,220: puts 54.0K OI (−80.5K), close 23.95, ₹16.6Cr notional in 274 trades · calls 1.46L OI (−41.9K), close 2.85, ₹39.2Cr notional in 614 trades

Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations4,505.25,533.86,207.55,237.05,269.16,527.96,573.76,123.26,864.57,587.08,017.07,909.6
Other income37.7156.463.268.257.580.6154.9109.0111.4134.2106.1129.9
Total income4,542.95,690.26,270.75,305.25,326.66,608.56,728.66,232.26,975.97,721.28,123.18,039.5
Total expenses3,617.44,143.24,371.04,034.34,142.54,716.94,808.04,510.65,537.65,664.06,798.36,806.6
└ Finance costs19.834.632.225.132.076.684.7101.3129.9123.0156.0187.0
└ Depreciation194.8205.3215.3233.6229.0237.9238.1301.9359.6508.4554.7604.5
Profit before tax925.51,547.01,899.71,270.91,184.11,672.01,920.61,687.41,353.41,659.71,306.61,234.2
Tax expense213.8321.2436.1373.1179.5423.2434.0454.0388.3318.4354.2334.0
Net profit789.91,246.11,482.5920.21,026.21,243.71,521.01,238.61,022.91,341.0990.2927.7
EPS7.8011.6914.119.0610.1711.6414.5812.5110.3612.659.359.28
Net margin17.53%22.52%23.88%17.57%19.48%19.05%23.14%20.23%14.90%17.67%12.35%11.73%
PBT margin20.54%27.96%30.60%24.27%22.47%25.61%29.22%27.56%19.72%21.88%16.30%15.60%
Tax rate23.10%20.76%22.96%29.36%15.16%25.31%22.60%26.91%28.69%19.18%27.11%27.06%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets25,756.425,879.429,280.831,445.937,201.746,897.352,406.655,606.9
Current assets10,008.29,928.211,419.812,118.817,046.118,312.919,906.118,433.5
└ Cash & equivalents487.8346.3413.01,061.4826.8881.6855.2669.2
└ Other bank balances85.3560.8692.1532.22,130.01,900.9561.4882.6
└ Current investments619.3612.4252.5901.44,851.14,286.05,775.83,664.1
└ Trade receivables4,416.83,915.25,220.24,669.54,024.74,962.75,415.74,380.7
└ Inventories3,413.33,303.93,441.93,716.93,944.04,750.15,628.16,882.2
Total equity19,688.320,940.922,101.624,154.626,358.428,089.929,582.230,322.8
└ Attributable to owners17,515.818,732.819,829.521,824.623,953.125,302.027,111.427,817.3
└ Non-controlling interest2,172.52,208.12,272.12,330.02,405.32,787.92,470.82,505.5
└ Share capital101.2101.2100.6100.6100.6100.6100.699.8
Borrowings1,163.2150.0768.6150.03,169.59,593.911,769.513,249.6
└ Current1,163.2150.0768.6150.03,169.52,814.88,581.59,143.4
└ Non-current0.00.00.00.00.06,779.13,188.04,106.2
Trade payables2,125.01,635.82,126.72,126.82,305.82,461.52,845.12,957.6
Current liabilities5,526.74,357.85,339.75,349.29,041.69,447.515,711.918,023.5
Total liabilities6,068.14,938.57,179.27,291.310,843.318,807.422,824.425,284.1
Net debt(29.2)(1,369.5)(589.0)(2,345.0)(4,638.4)2,525.44,577.18,033.7
Debt / equity0.060.010.030.010.120.340.400.44
Current ratio1.812.282.142.271.891.941.271.02

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow2,688.82,212.93,227.93,578.86,776.7946.02,116.63,162.3
└ Capex(1,030.9)(465.1)(906.6)(974.0)(1,712.6)(867.5)(3,394.0)(1,261.2)
Free cash flow1,657.91,747.82,321.32,604.85,064.178.5(1,277.4)1,901.1
Investing cash flow1,171.2(709.3)(1,475.2)(1,981.7)(8,372.3)(5,192.7)(8,296.1)(4,129.4)
Financing cash flow(4,400.4)(1,645.1)(1,804.4)(931.0)2,030.84,223.15,997.1774.1
└ Dividends paid(267.1)(620.7)(621.0)(302.9)(302.5)(1,105.7)(1,106.3)(99.7)
└ Buybacks(863.2)0.0(725.0)0.00.00.00.0(1,106.3)
Net change in cash(533.8)(141.5)(51.7)648.4413.8(23.6)(182.4)(186.0)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

ZYDUSLIFE at a glance

  • ZYDUSLIFE closed at ₹1,200 on 20 Nov 2026, -0.24% on the day, +27.1% over one year, 5.3% below its 52-week high of ₹1,266.6.
  • Delivery was 62.8% of traded quantity on 20 Nov 2026, the 79th percentile of its own 3,629 sessions with a reading (20-session average 50.2%, 1-year average 50.2%).
  • Market capitalisation is ₹1.20 lakh crore at a trailing P/E of 28.6 (trailing EPS ₹41.9).
  • Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹7,910 crore (+29.2% year on year), net profit ₹928 crore (-25.1%); the price moved +0.4% on the first session after.
  • Promoters held 75.01% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 3 Feb 2027 and 9 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE010B01027
SeriesEQ
Listed18 Apr 2000
Former symbolsCADILAHC (until 7 Mar 2022)
Former namesCadila Healthcare Limited (until 7 Mar 2022)
NSE market cap · 17 Nov 2026₹1.20L Cr
Free-float market cap (NSE)₹29,761 Cr
Shares outstanding (NSE)99.75Cr
History from27 Apr 2000
Sessions6,603
Turnover rank#151

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.